Clinical Trial Update: Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

View source ↗

Summary

A completed comparative clinical trial evaluated standard-dose versus low-dose pegylated interferon plus ribavirin for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kyoto University | Conditions: Hepatitis C, Chronic | Status: COMPLETED